OHDSI Home | Forums | Wiki | Github


Dexamethasone Cohort Building (4)
Cohort pathway: the unreasonable proporation (3)
Hematology projects? (3)
CohortMethod user group ( 2 3 4 ) (73)
Cohort pathway: why Persons with pathways portion are not equal to 100%? (5)
Empty cohort issue only occurred on KNN, Naive Bayes, Neural Network, DeepNN model (5)
Atlas: How to set index date to absolute day or to get_todays_date() (4)
Negative information in OMOP CDM (11)
Atlas Cohort Definition (Eligibility requirement of more than 1 occurrence of a diagnosis) (4)
Feature Analysis/Cohort Characterization Tool in ATLAS (3)
COVID-19 study-a-thon data (1)
COVID-19 infections in cancer patients (12)
[COVID-19] Prior immunization as protective for COVID-19 disease/bad outcomes (3)
[OHDSI Covid19] Literature review on viral prediction models ( 2 ) (23)
Forming external controls for comparative effectiveness estimation (3)
Do your Rx dispensation data have refills? (USA vs other countries) (6)
[Covid-19] Alpha-1 blocker as potential prophylaxis against ARDS ( 2 ) (22)
The result with fact_relationship table for antibiotics sensitivity test (6)
Estimation error: what is the mean of "Currently only MDRR for Cox is supported" when using atlas to do estimation? (6)
Study on readmission rates and complications after COVID-19 hospitalisation (10)
COVID and AKI ( 2 ) (30)
Is it possible to run a simple vocabulary query without having to download OMOP (2)
Definitions for Covid-19 severity - mild, moderate, severe (7)
Validation set- How can I identify COVID19 patients? (3)
Question about the concept set for "Cohort #279, Persons hospitalized with COVID-19, broad, w/ prior observation" (3)
Survey on how you use or make concept sets (5)
[OHDSI COVID-19] Review on the effect of ACE inhibitors and Angiotensin Receptor Blockers on COVID-19 incidence and complication rate ( 2 ) (29)
Network study: Concept Prevalence ( 2 ) (27)
[OHDSI Covid19] Literature review on Covid19 characterization ( 2 ) (22)